Abstract

Pregnancy is a complex state with many endocrinological challenges to a woman’s physiology. Gestational Hypothyroidism (GHT) is an emerging condition where insufficiency of the thyroid gland has developed during pregnancy in a previously euthyroid woman. It is different to overt hypothyroidism, where marked elevation of thyroid-stimulating hormone with corresponding reduction in free thyroxine levels, is well known to cause detrimental effects to both the mother and the baby. During the past couple of decades, it has been shown that GHT is associated with multiple adverse maternal and fetal outcomes such as miscarriage, pre-eclampsia, placental abruption, fetal loss, premature delivery, neurocognitive and neurobehavioral development. However, three randomized controlled trials and a prospective cohort study performed within the last decade, show that there is no neurodevelopmental improvement in the offspring of mothers who received levothyroxine treatment for GHT. Thus, the benefit of initiating treatment for GHT is highly debated within the clinical community as there may also be risks associated with over-treatment. In addition, regulatory mechanisms that could possibly lead to GHT during pregnancy are not well elucidated. This review aims to unravel pregnancy induced physiological challenges that could provide basis for the development of GHT. During pregnancy, there is increased renal clearance of iodine leading to low iodine state. Also, an elevated estrogen level leading to an increase in circulating thyroglobulin level and a decrease in free thyroxine level. Moreover, placenta secretes compounds such as human chorionic gonadotropin (hCG), placental growth factor (PIGF) and soluble FMS-like tyrosine kinase-1 (s-Flt1) that could affect the thyroid function. In turn, the passage of thyroid hormones and iodine to the fetus is highly regulated within the placental barrier. Together, these mechanisms are hypothesized to contribute to the development of intolerance of thyroid function leading to GHT in a vulnerable individual.

Highlights

  • Thyroid dysfunction during pregnancy is a well-researched area due to the detrimental effects of either profoundly low or high circulating thyroid hormones

  • We reinforce the term GHT (Gestational Hypothyroidism), for both subclinical hypothyroidism (SCH) and isolatedGestational Hypothyroidism hypothyroxinemia (IH) identified during pregnancy in women who were previously euthyroid

  • Due to high risk of SCH, Shi and his colleagues [48] suggests, upper limit of iodine intake during early pregnancy in iodine-sufficient regions should not exceed urinary iodine concertation (UIC) 250g/L while a UIC of 500g/L should not be exceeded due to significantly high risk of IH. Studies supporting both mild iodine deficiency and excess iodine intake leading to SCH during pregnancy have found pre-conception higher body mass index (BMI) to be a risk factor [40, 47]

Read more

Summary

Understanding the Pathogenesis of Gestational Hypothyroidism

Reviewed by: Yolanda De Rijke, Erasmus Medical Center, Netherlands Stefania Triunfo, BCNatal, Spain. Pregnancy is a complex state with many endocrinological challenges to a woman’s physiology. It is different to overt hypothyroidism, where marked elevation of thyroid-stimulating hormone with corresponding reduction in free thyroxine levels, is well known to cause detrimental effects to both the mother and the baby. This review aims to unravel pregnancy induced physiological challenges that could provide basis for the development of GHT. The passage of thyroid hormones and iodine to the fetus is highly regulated within the placental barrier. Together, these mechanisms are hypothesized to contribute to the development of intolerance of thyroid function leading to GHT in a vulnerable individual

INTRODUCTION
GHT IS ASSOCIATED WITH ADVERSE MATERNAL AND FETAL OUTCOMES
Role of Placenta
Role of Iodine
Role of Estrogen
Evidence From Studies Thus Far
Choice of Treatment of GHT?
DISCUSSION
Time of initiation of therapy
Assessments used
No significant differences of ADHD features between the children
No significant differences seen with cognitive and behavioral outcomes
Findings
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.